B2/B3混合型胸腺瘤腹壁转移1例并文献复习  

Abdominal wall metastasis of B2/B3 thymoma:a case report and literature review

作　　者：解昕 刘肖肖 李亮 章龙珍 Xie Xin;Liu Xiaoxiao;Li Liang;Zhang Longzhen(Department of Radiotherapy,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,China)

机构地区：[1]徐州医科大学附属医院放疗科,徐州221000

出　　处：《中华转移性肿瘤杂志》2022年第2期167-170,共4页Chinese Journal of Metastatic Cancer

基　　金：国家自然科学基金面上项目(81972845);2019年江苏省自然科学基金青年基金项目(BK20190989)。

摘　　要：胸腺瘤是起源于胸腺上皮细胞的肿瘤,是一种具有良性细胞学特征、恶性生物学行为的肿瘤,国内外文献有对胸腺瘤远处转移的报道,常见的转移部位有肺、肝、纵隔等,发生于腹壁的转移罕见报道,且没有有效的治疗方法。本文就1例B2/B3混合型胸腺瘤腹壁转移病例进行报告,并回顾国内外相关文献报道,总结晚期转移性胸腺瘤的治疗方法。通过对腹壁转移灶的放疗,联合GM-CSF的应用,患者腹壁病灶退缩明显且不良反应轻微。该病例为合并肌无力的晚期转移性胸腺瘤的患者提供了新的治疗手段。Thymoma is a tumor originated from thymic epithelial cells.It is a kind of tumor with benign cytological characteristics and malignant biological behavior.There are reports on distant metastasis of thymoma in domestic and foreign literatures.The common metastatic sites are lung,liver,mediastinum,etc.Abdominal wall metastasis is rarely reported,and there is no effective treatment.We reported a case of abdominal wall metastasis of B2/B3 thymoma,and recent cases at home and abroad were reviewed the literatures,in order to summarize and the treatment methods of advanced metastatic thymoma were summarized.Through the application of radiotherapy combined with GM-CSF on abdominal wall metastases,the abdominal wall lesions shrink shrunk significantly,and the side effects arewere mild.It provides a new treatment method for patients with advanced metastatic thymoma complicated with myasthenia.

关 键 词：胸腺瘤 肿瘤转移 放射疗法 免疫疗法 

分 类 号：R736.3[医药卫生—肿瘤]